These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


312 related items for PubMed ID: 24365043

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Medical management of acute superficial vein thrombosis of the saphenous vein.
    Scovell SD, Ergul EA, Conrad MF.
    J Vasc Surg Venous Lymphat Disord; 2018 Jan; 6(1):109-117. PubMed ID: 29097174
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of 3,000 IU aXa of the low molecular weight heparin certoparin with 5,000 IU aXa in prevention of deep vein thrombosis after total hip replacement. German Thrombosis Study Group.
    Adolf J, Fritsche HM, Haas S, Hennig FF, Horbach T, Kastl S, Koppenhagen K, Michaelis HC, Rhamanzadeh R, Summa W, Wagner W, Weber U, Wolf H.
    Int Angiol; 1999 Jun; 18(2):122-6. PubMed ID: 10424367
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
    Haas S, Breyer HG, Bacher HP, Fareed J, Misselwitz F, Victor N, Weber J, ECHOS Trial Group.
    Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
    [Abstract] [Full Text] [Related]

  • 16. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO, Silva MA, Donovan JL, Roy T, Al-Homsi AS.
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [Abstract] [Full Text] [Related]

  • 17. Diagnosis and treatment of superficial vein thrombosis.
    Bauersachs RM.
    Hamostaseologie; 2013 Aug 01; 33(3):232-40. PubMed ID: 23757000
    [Abstract] [Full Text] [Related]

  • 18. Predictive factors for concurrent deep-vein thrombosis and symptomatic venous thromboembolic recurrence in case of superficial venous thrombosis. The OPTIMEV study.
    Galanaud JP, Genty C, Sevestre MA, Brisot D, Lausecker M, Gillet JL, Rolland C, Righini M, Leftheriotis G, Bosson JL, Quere I, OPTIMEV SFMV investigators.
    Thromb Haemost; 2011 Jan 01; 105(1):31-9. PubMed ID: 20886192
    [Abstract] [Full Text] [Related]

  • 19. Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration.
    Simes J, Becattini C, Agnelli G, Eikelboom JW, Kirby AC, Mister R, Prandoni P, Brighton TA, INSPIRE Study Investigators (International Collaboration of Aspirin Trials for Recurrent Venous Thromboembolism).
    Circulation; 2014 Sep 23; 130(13):1062-71. PubMed ID: 25156992
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.